These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
588 related articles for article (PubMed ID: 32181991)
21. Multifunctional CuFe Chen N; Li Y; Li H; Wang Y; Zeng Y; Zhang M; Pan Z; Chen Z; Liang W; Huang J; Zhang K; Liu X; He Y Colloids Surf B Biointerfaces; 2023 Sep; 229():113445. PubMed ID: 37441838 [TBL] [Abstract][Full Text] [Related]
22. A biomimetic nanoplatform for precise reprogramming of tumor-associated macrophages and NIR-II mediated antitumor immune activation. Du Y; Qian X; Lin F; Gao B; Wang W; Yang H; Wang W; Ding Y Acta Biomater; 2023 May; 162():85-97. PubMed ID: 36948328 [TBL] [Abstract][Full Text] [Related]
23. Near-Infrared II Plasmonic Phototheranostics with Glutathione Depletion for Multimodal Imaging-Guided Hypoxia-Tolerant Chemodynamic-Photocatalytic-Photothermal Cancer Therapy Triggered by a Single Laser. Shan B; Liu H; Li L; Lu Y; Li M Small; 2022 Jan; 18(4):e2105638. PubMed ID: 34821041 [TBL] [Abstract][Full Text] [Related]
24. An Organic Nanotherapeutic Agent Self-Assembled from Cyanine and Cu (II) for Combined Photothermal and Chemodynamic Therapy. Li X; Xi D; Yang M; Sun W; Peng X; Fan J Adv Healthc Mater; 2021 Oct; 10(20):e2101008. PubMed ID: 34515401 [TBL] [Abstract][Full Text] [Related]
25. NIR-II responsive PEGylated nickel nanoclusters for photothermal enhanced chemodynamic synergistic oncotherapy. Qian Y; Zhang J; Zou J; Wang X; Meng X; Liu H; Lin Y; Chen Q; Sun L; Lin W; Wang H Theranostics; 2022; 12(8):3690-3702. PubMed ID: 35664059 [No Abstract] [Full Text] [Related]
26. An Activatable Phototheranostic Nanoplatform for Tumor Specific NIR-II Fluorescence Imaging and Synergistic NIR-II Photothermal-Chemodynamic Therapy. Dai Y; Zhang F; Chen K; Sun Z; Wang Z; Xue Y; Li M; Fan Q; Shen Q; Zhao Q Small; 2023 Jun; 19(22):e2206053. PubMed ID: 36852618 [TBL] [Abstract][Full Text] [Related]
27. Recent Advances in Single Fe-Based Nanoagents for Photothermal-Chemodynamic Cancer Therapy. Zhang L; Forgham H; Shen A; Qiao R; Guo B Biosensors (Basel); 2022 Jan; 12(2):. PubMed ID: 35200346 [TBL] [Abstract][Full Text] [Related]
28. Chiral Cu Liu Y; Li H; Li S; Zhang X; Xiong J; Jiang F; Liu Y; Jiang P ACS Appl Mater Interfaces; 2021 Dec; 13(51):60933-60944. PubMed ID: 34923825 [TBL] [Abstract][Full Text] [Related]
29. Copper-based theranostic nanocatalysts for synergetic photothermal-chemodynamic therapy. Zuo W; Fan Z; Chen L; Liu J; Wan Z; Xiao Z; Chen W; Wu L; Chen D; Zhu X Acta Biomater; 2022 Jul; 147():258-269. PubMed ID: 35605954 [TBL] [Abstract][Full Text] [Related]
30. Intelligent responsive copper-diethyldithiocarbamate-based multifunctional nanomedicine for photothermal-augmented synergistic cancer therapy. Meng X; Wu J; Hu Z; Zheng X J Mater Chem B; 2024 Jan; 12(5):1285-1295. PubMed ID: 38189142 [TBL] [Abstract][Full Text] [Related]
31. Facile Synthesis of Fe Qi C; Wang W; Wang P; Cheng H; Wang X; Gong B; Xie A; Shen Y Molecules; 2022 Jun; 27(13):. PubMed ID: 35807249 [TBL] [Abstract][Full Text] [Related]
32. Dual source-powered multifunctional Pt/FePc@Mn-MOF spindle-like Janus nanomotors for active CT imaging-guided synergistic photothermal/chemodynamic therapy. Zhang X; Liu C; Li J; Chu R; Lyu Y; Lan Z J Colloid Interface Sci; 2024 Mar; 657():799-810. PubMed ID: 38081114 [TBL] [Abstract][Full Text] [Related]
33. A Multifunctional Nanoreactor-Induced Dual Inhibition of HSP70 Strategy for Enhancing Mild Photothermal/Chemodynamic Synergistic Tumor Therapy. Wu S; Gao M; Chen L; Wang Y; Zheng X; Zhang B; Li J; Zhang XD; Dai R; Zheng Z; Zhang R Adv Healthc Mater; 2024 Sep; 13(23):e2400819. PubMed ID: 38722289 [TBL] [Abstract][Full Text] [Related]
34. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy. Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955 [TBL] [Abstract][Full Text] [Related]
35. CeO Yan Y; Hou Y; Zhang H; Gao W; Han R; Yu J; Xu L; Tang K Colloids Surf B Biointerfaces; 2021 Dec; 208():112103. PubMed ID: 34509084 [TBL] [Abstract][Full Text] [Related]
36. Photothermal nanozymes to self-augment combination cancer therapy by dual-glutathione depletion and hyperthermia/acidity-activated hydroxyl radical generation. Wang TH; Shen MY; Yeh NT; Chen YH; Hsu TC; Chin HY; Wu YT; Tzang BS; Chiang WH J Colloid Interface Sci; 2023 Nov; 650(Pt B):1698-1714. PubMed ID: 37499626 [TBL] [Abstract][Full Text] [Related]
37. Interfacial engineered gadolinium oxide nanoparticles for magnetic resonance imaging guided microenvironment-mediated synergetic chemodynamic/photothermal therapy. Zhao Z; Xu K; Fu C; Liu H; Lei M; Bao J; Fu A; Yu Y; Zhang W Biomaterials; 2019 Oct; 219():119379. PubMed ID: 31376746 [TBL] [Abstract][Full Text] [Related]
38. Prussian Blue-Derived Nanoplatform for In Situ Amplified Photothermal/Chemodynamic/Starvation Therapy. Liang J; Sun Y; Wang K; Zhang Y; Guo L; Bao Z; Wang D; Xu H; Zheng J; Yuan Y ACS Appl Mater Interfaces; 2023 Apr; 15(14):18191-18204. PubMed ID: 36975190 [TBL] [Abstract][Full Text] [Related]
39. Photonic cancer nanomedicine using the near infrared-II biowindow enabled by biocompatible titanium nitride nanoplatforms. Wang C; Dai C; Hu Z; Li H; Yu L; Lin H; Bai J; Chen Y Nanoscale Horiz; 2019 Mar; 4(2):415-425. PubMed ID: 32254094 [TBL] [Abstract][Full Text] [Related]
40. Gold nanobipyramid@copper sulfide nanotheranostics for image-guided NIR-II photo/chemodynamic cancer therapy with enhanced immune response. Chen Y; Liu P; Zhou C; Zhang T; Zhou T; Men D; Jiang G; Hang L Acta Biomater; 2023 Mar; 158():649-659. PubMed ID: 36623783 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]